Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery

PURPOSE: Iron deficiency is common following bariatric surgery, and treatment with intravenous iron is often required. This post hoc analysis of data from two randomized, open-label, multicenter trials evaluated the efficacy and safety of ferric derisomaltose (FDI; formerly iron isomaltoside 1000) v...

Descripción completa

Detalles Bibliográficos
Autores principales: Auerbach, Michael, Achebe, Maureen M., Thomsen, Lars L., Derman, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866325/
https://www.ncbi.nlm.nih.gov/pubmed/35000068
http://dx.doi.org/10.1007/s11695-021-05858-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866325/
https://www.ncbi.nlm.nih.gov/pubmed/35000068
http://dx.doi.org/10.1007/s11695-021-05858-0

Ejemplares similares